Bfi Infinity Ltd. Abb Vie Inc. Transaction History
Bfi Infinity Ltd.
- $92.6 Billion
- Q1 2025
A detailed history of Bfi Infinity Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Bfi Infinity Ltd. holds 2,497 shares of ABBV stock, worth $487,164. This represents 0.57% of its overall portfolio holdings.
Number of Shares
2,497
Previous 2,055
21.51%
Holding current value
$487,164
Previous $365 Million
43.27%
% of portfolio
0.57%
Previous 0.4%
Shares
2 transactions
Others Institutions Holding ABBV
# of Institutions
4,184Shares Held
1.29BCall Options Held
17.1MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA173MShares$33.8 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.6 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$15.5 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10.1 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$7.74 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $345B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...